GRDN (Guardian Pharmacy Services) 3-Year Revenue Growth Rate : 15.00% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Guardian Pharmacy Services 3-Year Revenue Growth Rate?

Guardian Pharmacy Services's Revenue per Share for the three months ended in Dec. 2024 was $5.24.

During the past 12 months, Guardian Pharmacy Services's average Revenue per Share Growth Rate was 15.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 15.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of Guardian Pharmacy Services was 15.00% per year. The lowest was 9.20% per year. And the median was 11.05% per year.

Competitive Comparison of Guardian Pharmacy Services's 3-Year Revenue Growth Rate

For the Medical Care Facilities subindustry, Guardian Pharmacy Services's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guardian Pharmacy Services's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Guardian Pharmacy Services's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Guardian Pharmacy Services's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Guardian Pharmacy Services 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Guardian Pharmacy Services (NYSE:GRDN) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Guardian Pharmacy Services 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Guardian Pharmacy Services's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Guardian Pharmacy Services Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Guardian Pharmacy Services Inc (NYSE:GRDN) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

300 Galleria Parkway SE, Suite 800, Atlanta, GA, USA, 30339

Website

https://www.guardianpharmacy.com

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.